Ignite Creation Date:
2024-05-06 @ 12:54 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03875495
Status:
TERMINATED
Last Update Posted:
2022-01-28
First Post:
2019-03-13
Brief Title:
A Phase III Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy TEM-MM
Sponsor:
Genenta Science
Organization:
Genenta Science
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-06
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-02
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-13
First Submit QC Date:
March 13 2019
Study First Post Date:
2019-03-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-01-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-27
Last Update Post Date:
2022-01-28
Last Update Post Date Type:
ACTUAL